Lilly stock cycles on the results of the oral fictional trial
Eli Lilly and Company today Lly Elie lil and company $ 827.87 +9.85 (+ 1.20%) 04/22/2025 as 03:59 am Eastern ...
Read more
Novo Nordisk (NVO) determines scenes on dominate the SLP-1 market
Novo Nordisk A / s Nyse: nvo The brand under ozpatic and air-Airs, for an old obesity for an old ...
Read more
These 3 stocks announced the big dividend increase
Highlights
Three billion dollars three firms increased their dividend payments.
A big Forma name increased its normal payment ...
Read more
Does the AnoO Stock near the less than 52-week less this is the opportunity?
Novo Nordisk A / S Nvo Novo Nordisk A / s $ 77.94 -0.89 (-1.11%) 02/14/2025 as 03:59 am Eastern ...
Read more
GE Healthcare and Novo Nordisk: Ultrasound tech stocks boost
The advent of GLP-1 therapies has been a game changer Medical sector For weight loss and chronic obesity. The GLP-1 ...
Read more
CEO Dave Ricks says Lilly’s weight loss pill, or foragliprone, could get FDA approval in 2026
Eli Lilly & Co., the Fortune 500 pharma firm that makes the weight-loss injection Zepbound (tirzepetide), has a comparable oral ...
Read more
3 Great Stocks That Can Enjoy a Santa Claus Rally
Santa Claus will soon be on his way to deliver gifts to children around the world. But can the jolly ...
Read more
MASH approval could revive GLP-1 sales
Novo Nordisk A/S today NVO Novo Nordisk A/S $108.47 +0.46 (+0.43%) (as of 10:27 AM ET) 52-week range $99.42 ▼ ...
Read more
Lilly-funded clinical trial says Zapbound (tirzepetide) superior to Vegovi (semaglutide)
In the midst of the war on obesity, a battle between two weight loss vaccines has emerged as a clear ...
Read more
